                               SEQUENCE LISTING

<110> SANGAMO THERAPEUTICS, INC.
 
<120> COMPOSITIONS AND METHODS FOR PRODUCING RECOMBINANT AAV

<130> 025297.WO004

<140>
<141>

<150> 62/806,317
<151> 2019-02-15

<160> 56    

<170> PatentIn version 3.5

<210> 1
<211> 736
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Thr" or "Leu" or "Val"

<220>
<221> SITE
<222> (1)..(736)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 1
Met Ala Ala Asp Gly Tyr Leu Pro Asp Trp Leu Glu Asp Asn Leu Ser 
1               5                   10                  15      


Glu Gly Ile Arg Glu Trp Trp Asp Leu Lys Pro Gly Ala Pro Lys Pro 
            20                  25                  30          


Lys Ala Asn Gln Gln Lys Gln Asp Asp Gly Arg Gly Leu Val Leu Pro 
        35                  40                  45              


Gly Tyr Lys Tyr Leu Gly Pro Phe Asn Gly Leu Asp Lys Gly Glu Pro 
    50                  55                  60                  


Val Asn Ala Ala Asp Ala Ala Ala Leu Glu His Asp Lys Ala Tyr Asp 
65                  70                  75                  80  


Gln Gln Leu Lys Ala Gly Asp Asn Pro Tyr Leu Arg Tyr Asn His Ala 
                85                  90                  95      


Asp Ala Glu Phe Gln Glu Arg Leu Gln Glu Asp Thr Ser Phe Gly Gly 
            100                 105                 110         


Asn Leu Gly Arg Ala Val Phe Gln Ala Lys Lys Arg Val Leu Glu Pro 
        115                 120                 125             


Phe Gly Leu Val Glu Glu Gly Ala Lys Thr Ala Pro Gly Lys Lys Arg 
    130                 135                 140                 


Pro Val Glu Gln Ser Pro Gln Glu Pro Asp Ser Ser Ser Gly Ile Gly 
145                 150                 155                 160 


Lys Thr Gly Gln Gln Pro Ala Lys Lys Arg Leu Asn Phe Gly Gln Thr 
                165                 170                 175     


Gly Asp Ser Glu Ser Val Pro Asp Pro Gln Pro Leu Gly Glu Pro Pro 
            180                 185                 190         


Ala Thr Pro Ala Ala Val Gly Pro Thr Thr Met Ala Ser Gly Gly Gly 
        195                 200                 205             


Ala Pro Met Ala Asp Asn Asn Glu Gly Ala Asp Gly Val Gly Asn Ala 
    210                 215                 220                 


Ser Gly Asn Trp His Cys Asp Ser Thr Trp Leu Gly Asp Arg Val Ile 
225                 230                 235                 240 


Thr Thr Ser Thr Arg Thr Trp Ala Leu Pro Thr Tyr Asn Asn His Leu 
                245                 250                 255     


Tyr Lys Gln Ile Ser Ser Ala Ser Thr Gly Ala Ser Asn Asp Asn His 
            260                 265                 270         


Tyr Phe Gly Tyr Ser Thr Pro Trp Gly Tyr Phe Asp Phe Asn Arg Phe 
        275                 280                 285             


His Cys His Phe Ser Pro Arg Asp Trp Gln Arg Leu Ile Asn Asn Asn 
    290                 295                 300                 


Trp Gly Phe Arg Pro Lys Arg Leu Asn Phe Lys Leu Phe Asn Ile Gln 
305                 310                 315                 320 


Val Lys Glu Val Thr Thr Asn Asp Gly Val Thr Thr Ile Ala Asn Asn 
                325                 330                 335     


Leu Thr Ser Thr Val Gln Val Phe Ser Asp Ser Glu Tyr Gln Leu Pro 
            340                 345                 350         


Tyr Val Leu Gly Ser Ala His Gln Gly Cys Leu Pro Pro Phe Pro Ala 
        355                 360                 365             


Asp Val Phe Met Ile Pro Gln Tyr Gly Tyr Leu Thr Leu Asn Asn Gly 
    370                 375                 380                 


Ser Gln Ala Val Gly Arg Ser Ser Phe Tyr Cys Leu Glu Tyr Phe Pro 
385                 390                 395                 400 


Ser Gln Met Leu Arg Thr Gly Asn Asn Phe Thr Phe Ser Tyr Thr Phe 
                405                 410                 415     


Glu Asp Val Pro Phe His Ser Ser Tyr Ala His Ser Gln Ser Leu Asp 
            420                 425                 430         


Arg Leu Met Asn Pro Leu Ile Asp Gln Tyr Leu Tyr Tyr Leu Asn Arg 
        435                 440                 445             


Thr Gln Asn Gln Ser Gly Ser Ala Gln Asn Lys Asp Leu Leu Phe Ser 
    450                 455                 460                 


Arg Gly Ser Pro Ala Gly Met Ser Val Gln Pro Lys Asn Trp Leu Pro 
465                 470                 475                 480 


Gly Pro Cys Tyr Arg Gln Gln Arg Val Ser Lys Thr Lys Thr Asp Asn 
                485                 490                 495     


Asn Asn Ser Asn Phe Thr Trp Thr Gly Ala Ser Lys Tyr Asn Leu Asn 
            500                 505                 510         


Gly Arg Glu Ser Ile Ile Asn Pro Gly Thr Ala Met Ala Ser His Lys 
        515                 520                 525             


Asp Asp Lys Asp Lys Phe Phe Pro Met Ser Gly Val Met Ile Phe Gly 
    530                 535                 540                 


Lys Glu Ser Ala Gly Ala Ser Asn Thr Ala Leu Asp Asn Val Met Ile 
545                 550                 555                 560 


Thr Asp Glu Glu Glu Ile Lys Ala Thr Asn Pro Val Ala Thr Glu Arg 
                565                 570                 575     


Phe Gly Thr Val Ala Val Asn Leu Gln Ser Ser Ser Thr Asp Pro Ala 
            580                 585                 590         


Thr Gly Asp Val His Val Met Gly Ala Leu Pro Gly Met Val Trp Gln 
        595                 600                 605             


Asp Arg Asp Val Tyr Leu Gln Gly Pro Ile Trp Ala Lys Ile Pro His 
    610                 615                 620                 


Thr Asp Gly His Phe His Pro Ser Pro Leu Met Gly Gly Phe Gly Leu 
625                 630                 635                 640 


Lys His Pro Pro Pro Gln Ile Leu Ile Lys Asn Thr Pro Val Pro Ala 
                645                 650                 655     


Asn Pro Pro Ala Glu Phe Ser Ala Thr Lys Phe Ala Ser Phe Ile Thr 
            660                 665                 670         


Gln Tyr Ser Thr Gly Gln Val Ser Val Glu Ile Glu Trp Glu Leu Gln 
        675                 680                 685             


Lys Glu Asn Ser Lys Arg Trp Asn Pro Glu Val Gln Tyr Thr Ser Asn 
    690                 695                 700                 


Tyr Ala Lys Ser Ala Asn Val Asp Phe Thr Val Asp Asn Asn Gly Leu 
705                 710                 715                 720 


Tyr Thr Glu Pro Arg Pro Ile Gly Thr Arg Tyr Leu Thr Arg Pro Leu 
                725                 730                 735     


<210> 2
<211> 10
<212> PRT
<213> Adeno-associated virus

<400> 2
Pro Gln Pro Leu Gly Glu Pro Pro Ala Thr 
1               5                   10  


<210> 3
<211> 45
<212> PRT
<213> Adeno-associated virus

<400> 3
Ser Gly Ile Gly Lys Thr Gly Gln Gln Pro Ala Lys Lys Arg Leu Asn 
1               5                   10                  15      


Phe Gly Gln Thr Gly Asp Ser Glu Ser Val Pro Asp Pro Gln Pro Leu 
            20                  25                  30          


Gly Glu Pro Pro Ala Thr Pro Ala Ala Val Gly Pro Thr 
        35                  40                  45  


<210> 4
<211> 45
<212> PRT
<213> Adeno-associated virus

<400> 4
Ala Gly Ile Gly Lys Ser Gly Ala Gln Pro Ala Lys Lys Arg Leu Asn 
1               5                   10                  15      


Phe Gly Gln Thr Gly Asp Thr Glu Ser Val Pro Asp Pro Gln Pro Ile 
            20                  25                  30          


Gly Glu Pro Pro Ala Ala Pro Ser Gly Val Gly Ser Leu 
        35                  40                  45  


<210> 5
<211> 46
<212> PRT
<213> Adeno-associated virus

<400> 5
Tyr Leu Gly Pro Phe Asn Gly Leu Asp Lys Gly Glu Pro Val Asn Ala 
1               5                   10                  15      


Ala Asp Ala Ala Ala Leu Glu His Asp Lys Ala Tyr Asp Gln Gln Leu 
            20                  25                  30          


Lys Ala Gly Asp Asn Pro Tyr Leu Arg Tyr Asn His Ala Asp 
        35                  40                  45      


<210> 6
<211> 46
<212> PRT
<213> Adeno-associated virus

<400> 6
Tyr Leu Gly Pro Phe Asn Gly Leu Asp Lys Gly Glu Pro Val Asn Glu 
1               5                   10                  15      


Ala Asp Ala Ala Ala Leu Glu His Asp Lys Ala Tyr Asp Arg Gln Leu 
            20                  25                  30          


Asp Ser Gly Asp Asn Pro Tyr Leu Lys Tyr Asn His Ala Asp 
        35                  40                  45      


<210> 7
<211> 736
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 7
Met Ala Ala Asp Gly Tyr Leu Pro Asp Trp Leu Glu Asp Asn Leu Ser 
1               5                   10                  15      


Glu Gly Ile Arg Glu Trp Trp Asp Leu Lys Pro Gly Ala Pro Lys Pro 
            20                  25                  30          


Lys Ala Asn Gln Gln Lys Gln Asp Asp Gly Arg Gly Leu Val Leu Pro 
        35                  40                  45              


Gly Tyr Lys Tyr Leu Gly Pro Phe Asn Gly Leu Asp Lys Gly Glu Pro 
    50                  55                  60                  


Val Asn Glu Ala Asp Ala Ala Ala Leu Glu His Asp Lys Ala Tyr Asp 
65                  70                  75                  80  


Arg Gln Leu Asp Ser Gly Asp Asn Pro Tyr Leu Lys Tyr Asn His Ala 
                85                  90                  95      


Asp Ala Glu Phe Gln Glu Arg Leu Gln Glu Asp Thr Ser Phe Gly Gly 
            100                 105                 110         


Asn Leu Gly Arg Ala Val Phe Gln Ala Lys Lys Arg Val Leu Glu Pro 
        115                 120                 125             


Phe Gly Leu Val Glu Glu Gly Ala Lys Thr Ala Pro Gly Lys Lys Arg 
    130                 135                 140                 


Pro Val Glu Gln Ser Pro Gln Glu Pro Asp Ser Ser Ala Gly Ile Gly 
145                 150                 155                 160 


Lys Ser Gly Ala Gln Pro Ala Lys Lys Arg Leu Asn Phe Gly Gln Thr 
                165                 170                 175     


Gly Asp Thr Glu Ser Val Pro Asp Pro Gln Pro Ile Gly Glu Pro Pro 
            180                 185                 190         


Ala Ala Pro Ser Gly Val Gly Ser Leu Thr Met Ala Ser Gly Gly Gly 
        195                 200                 205             


Ala Pro Met Ala Asp Asn Asn Glu Gly Ala Asp Gly Val Gly Asn Ala 
    210                 215                 220                 


Ser Gly Asn Trp His Cys Asp Ser Thr Trp Leu Gly Asp Arg Val Ile 
225                 230                 235                 240 


Thr Thr Ser Thr Arg Thr Trp Ala Leu Pro Thr Tyr Asn Asn His Leu 
                245                 250                 255     


Tyr Lys Gln Ile Ser Ser Ala Ser Thr Gly Ala Ser Asn Asp Asn His 
            260                 265                 270         


Tyr Phe Gly Tyr Ser Thr Pro Trp Gly Tyr Phe Asp Phe Asn Arg Phe 
        275                 280                 285             


His Cys His Phe Ser Pro Arg Asp Trp Gln Arg Leu Ile Asn Asn Asn 
    290                 295                 300                 


Trp Gly Phe Arg Pro Lys Arg Leu Asn Phe Lys Leu Phe Asn Ile Gln 
305                 310                 315                 320 


Val Lys Glu Val Thr Thr Asn Asp Gly Val Thr Thr Ile Ala Asn Asn 
                325                 330                 335     


Leu Thr Ser Thr Val Gln Val Phe Ser Asp Ser Glu Tyr Gln Leu Pro 
            340                 345                 350         


Tyr Val Leu Gly Ser Ala His Gln Gly Cys Leu Pro Pro Phe Pro Ala 
        355                 360                 365             


Asp Val Phe Met Ile Pro Gln Tyr Gly Tyr Leu Thr Leu Asn Asn Gly 
    370                 375                 380                 


Ser Gln Ala Val Gly Arg Ser Ser Phe Tyr Cys Leu Glu Tyr Phe Pro 
385                 390                 395                 400 


Ser Gln Met Leu Arg Thr Gly Asn Asn Phe Thr Phe Ser Tyr Thr Phe 
                405                 410                 415     


Glu Asp Val Pro Phe His Ser Ser Tyr Ala His Ser Gln Ser Leu Asp 
            420                 425                 430         


Arg Leu Met Asn Pro Leu Ile Asp Gln Tyr Leu Tyr Tyr Leu Asn Arg 
        435                 440                 445             


Thr Gln Asn Gln Ser Gly Ser Ala Gln Asn Lys Asp Leu Leu Phe Ser 
    450                 455                 460                 


Arg Gly Ser Pro Ala Gly Met Ser Val Gln Pro Lys Asn Trp Leu Pro 
465                 470                 475                 480 


Gly Pro Cys Tyr Arg Gln Gln Arg Val Ser Lys Thr Lys Thr Asp Asn 
                485                 490                 495     


Asn Asn Ser Asn Phe Thr Trp Thr Gly Ala Ser Lys Tyr Asn Leu Asn 
            500                 505                 510         


Gly Arg Glu Ser Ile Ile Asn Pro Gly Thr Ala Met Ala Ser His Lys 
        515                 520                 525             


Asp Asp Lys Asp Lys Phe Phe Pro Met Ser Gly Val Met Ile Phe Gly 
    530                 535                 540                 


Lys Glu Ser Ala Gly Ala Ser Asn Thr Ala Leu Asp Asn Val Met Ile 
545                 550                 555                 560 


Thr Asp Glu Glu Glu Ile Lys Ala Thr Asn Pro Val Ala Thr Glu Arg 
                565                 570                 575     


Phe Gly Thr Val Ala Val Asn Leu Gln Ser Ser Ser Thr Asp Pro Ala 
            580                 585                 590         


Thr Gly Asp Val His Val Met Gly Ala Leu Pro Gly Met Val Trp Gln 
        595                 600                 605             


Asp Arg Asp Val Tyr Leu Gln Gly Pro Ile Trp Ala Lys Ile Pro His 
    610                 615                 620                 


Thr Asp Gly His Phe His Pro Ser Pro Leu Met Gly Gly Phe Gly Leu 
625                 630                 635                 640 


Lys His Pro Pro Pro Gln Ile Leu Ile Lys Asn Thr Pro Val Pro Ala 
                645                 650                 655     


Asn Pro Pro Ala Glu Phe Ser Ala Thr Lys Phe Ala Ser Phe Ile Thr 
            660                 665                 670         


Gln Tyr Ser Thr Gly Gln Val Ser Val Glu Ile Glu Trp Glu Leu Gln 
        675                 680                 685             


Lys Glu Asn Ser Lys Arg Trp Asn Pro Glu Val Gln Tyr Thr Ser Asn 
    690                 695                 700                 


Tyr Ala Lys Ser Ala Asn Val Asp Phe Thr Val Asp Asn Asn Gly Leu 
705                 710                 715                 720 


Tyr Thr Glu Pro Arg Pro Ile Gly Thr Arg Tyr Leu Thr Arg Pro Leu 
                725                 730                 735     


<210> 8
<211> 30
<212> PRT
<213> Adeno-associated virus

<400> 8
Met Ala Thr Gln Ser Gln Ser Pro Thr His Asn Leu Ser Glu Asn Leu 
1               5                   10                  15      


Gln Gln Pro Pro Leu Leu Trp Asp Leu Leu Gln Trp Leu Gln 
            20                  25                  30  


<210> 9
<211> 30
<212> PRT
<213> Adeno-associated virus

<400> 9
Met Ala Thr Gln Ser Gln Ser Gln Thr Leu Asn Gln Ser Glu Asn Leu 
1               5                   10                  15      


Pro Gln Pro Pro Gln Val Trp Asp Leu Leu Gln Trp Leu Gln 
            20                  25                  30  


<210> 10
<211> 196
<212> PRT
<213> Adeno-associated virus

<400> 10
Met Ala Thr Gln Ser Gln Ser Pro Thr His Asn Leu Ser Glu Asn Leu 
1               5                   10                  15      


Gln Gln Pro Pro Leu Leu Trp Asp Leu Leu Gln Trp Leu Gln Ala Val 
            20                  25                  30          


Ala His Gln Trp Gln Thr Ile Thr Lys Ala Pro Thr Glu Trp Val Met 
        35                  40                  45              


Pro Gln Glu Ile Gly Ile Ala Ile Pro His Gly Trp Ala Thr Glu Ser 
    50                  55                  60                  


Ser Pro Pro Ala Pro Glu His Gly Pro Cys Pro Pro Ile Thr Thr Thr 
65                  70                  75                  80  


Ser Thr Ser Lys Ser Pro Val Leu Gln Arg Gly Pro Ala Thr Thr Thr 
                85                  90                  95      


Thr Thr Ser Ala Thr Ala Pro Pro Gly Gly Ile Leu Ile Ser Thr Asp 
            100                 105                 110         


Ser Thr Ala Ile Ser His His Val Thr Gly Ser Asp Ser Ser Thr Thr 
        115                 120                 125             


Ile Gly Asp Ser Gly Pro Arg Asp Ser Thr Ser Ser Ser Ser Thr Ser 
    130                 135                 140                 


Lys Ser Arg Arg Ser Arg Arg Met Met Ala Ser Arg Pro Ser Leu Ile 
145                 150                 155                 160 


Thr Leu Pro Ala Arg Phe Lys Ser Ser Arg Thr Arg Ser Thr Ser Cys 
                165                 170                 175     


Arg Thr Ser Ser Ala Leu Arg Thr Arg Ala Ala Ser Leu Arg Ser Arg 
            180                 185                 190         


Arg Thr Cys Ser 
        195     


<210> 11
<211> 736
<212> PRT
<213> Adeno-associated virus

<400> 11
Met Ala Ala Asp Gly Tyr Leu Pro Asp Trp Leu Glu Asp Asn Leu Ser 
1               5                   10                  15      


Glu Gly Ile Arg Glu Trp Trp Ala Leu Lys Pro Gly Ala Pro Gln Pro 
            20                  25                  30          


Lys Ala Asn Gln Gln His Gln Asp Asn Ala Arg Gly Leu Val Leu Pro 
        35                  40                  45              


Gly Tyr Lys Tyr Leu Gly Pro Gly Asn Gly Leu Asp Lys Gly Glu Pro 
    50                  55                  60                  


Val Asn Ala Ala Asp Ala Ala Ala Leu Glu His Asp Lys Ala Tyr Asp 
65                  70                  75                  80  


Gln Gln Leu Lys Ala Gly Asp Asn Pro Tyr Leu Lys Tyr Asn His Ala 
                85                  90                  95      


Asp Ala Glu Phe Gln Glu Arg Leu Lys Glu Asp Thr Ser Phe Gly Gly 
            100                 105                 110         


Asn Leu Gly Arg Ala Val Phe Gln Ala Lys Lys Arg Leu Leu Glu Pro 
        115                 120                 125             


Leu Gly Leu Val Glu Glu Ala Ala Lys Thr Ala Pro Gly Lys Lys Arg 
    130                 135                 140                 


Pro Val Glu Gln Ser Pro Gln Glu Pro Asp Ser Ser Ala Gly Ile Gly 
145                 150                 155                 160 


Lys Ser Gly Ala Gln Pro Ala Lys Lys Arg Leu Asn Phe Gly Gln Thr 
                165                 170                 175     


Gly Asp Thr Glu Ser Val Pro Asp Pro Gln Pro Ile Gly Glu Pro Pro 
            180                 185                 190         


Ala Ala Pro Ser Gly Val Gly Ser Leu Thr Met Ala Ser Gly Gly Gly 
        195                 200                 205             


Ala Pro Val Ala Asp Asn Asn Glu Gly Ala Asp Gly Val Gly Ser Ser 
    210                 215                 220                 


Ser Gly Asn Trp His Cys Asp Ser Gln Trp Leu Gly Asp Arg Val Ile 
225                 230                 235                 240 


Thr Thr Ser Thr Arg Thr Trp Ala Leu Pro Thr Tyr Asn Asn His Leu 
                245                 250                 255     


Tyr Lys Gln Ile Ser Asn Ser Thr Ser Gly Gly Ser Ser Asn Asp Asn 
            260                 265                 270         


Ala Tyr Phe Gly Tyr Ser Thr Pro Trp Gly Tyr Phe Asp Phe Asn Arg 
        275                 280                 285             


Phe His Cys His Phe Ser Pro Arg Asp Trp Gln Arg Leu Ile Asn Asn 
    290                 295                 300                 


Asn Trp Gly Phe Arg Pro Lys Arg Leu Asn Phe Lys Leu Phe Asn Ile 
305                 310                 315                 320 


Gln Val Lys Glu Val Thr Asp Asn Asn Gly Val Lys Thr Ile Ala Asn 
                325                 330                 335     


Asn Leu Thr Ser Thr Val Gln Val Phe Thr Asp Ser Asp Tyr Gln Leu 
            340                 345                 350         


Pro Tyr Val Leu Gly Ser Ala His Glu Gly Cys Leu Pro Pro Phe Pro 
        355                 360                 365             


Ala Asp Val Phe Met Ile Pro Gln Tyr Gly Tyr Leu Thr Leu Asn Asp 
    370                 375                 380                 


Gly Ser Gln Ala Val Gly Arg Ser Ser Phe Tyr Cys Leu Glu Tyr Phe 
385                 390                 395                 400 


Pro Ser Gln Met Leu Arg Thr Gly Asn Asn Phe Gln Phe Ser Tyr Glu 
                405                 410                 415     


Phe Glu Asn Val Pro Phe His Ser Ser Tyr Ala His Ser Gln Ser Leu 
            420                 425                 430         


Asp Arg Leu Met Asn Pro Leu Ile Asp Gln Tyr Leu Tyr Tyr Leu Ser 
        435                 440                 445             


Lys Thr Ile Asn Gly Ser Gly Gln Asn Gln Gln Thr Leu Lys Phe Ser 
    450                 455                 460                 


Val Ala Gly Pro Ser Asn Met Ala Val Gln Gly Arg Asn Tyr Ile Pro 
465                 470                 475                 480 


Gly Pro Ser Tyr Arg Gln Gln Arg Val Ser Thr Thr Val Thr Gln Asn 
                485                 490                 495     


Asn Asn Ser Glu Phe Ala Trp Pro Gly Ala Ser Ser Trp Ala Leu Asn 
            500                 505                 510         


Gly Arg Asn Ser Leu Met Asn Pro Gly Pro Ala Met Ala Ser His Lys 
        515                 520                 525             


Glu Gly Glu Asp Arg Phe Phe Pro Leu Ser Gly Ser Leu Ile Phe Gly 
    530                 535                 540                 


Lys Gln Gly Thr Gly Arg Asp Asn Val Asp Ala Asp Lys Val Met Ile 
545                 550                 555                 560 


Thr Asn Glu Glu Glu Ile Lys Thr Thr Asn Pro Val Ala Thr Glu Ser 
                565                 570                 575     


Tyr Gly Gln Val Ala Thr Asn His Gln Ser Ala Gln Ala Gln Ala Gln 
            580                 585                 590         


Thr Gly Trp Val Gln Asn Gln Gly Ile Leu Pro Gly Met Val Trp Gln 
        595                 600                 605             


Asp Arg Asp Val Tyr Leu Gln Gly Pro Ile Trp Ala Lys Ile Pro His 
    610                 615                 620                 


Thr Asp Gly Asn Phe His Pro Ser Pro Leu Met Gly Gly Phe Gly Met 
625                 630                 635                 640 


Lys His Pro Pro Pro Gln Ile Leu Ile Lys Asn Thr Pro Val Pro Ala 
                645                 650                 655     


Asp Pro Pro Thr Ala Phe Asn Lys Asp Lys Leu Asn Ser Phe Ile Thr 
            660                 665                 670         


Gln Tyr Ser Thr Gly Gln Val Ser Val Glu Ile Glu Trp Glu Leu Gln 
        675                 680                 685             


Lys Glu Asn Ser Lys Arg Trp Asn Pro Glu Ile Gln Tyr Thr Ser Asn 
    690                 695                 700                 


Tyr Tyr Lys Ser Asn Asn Val Glu Phe Ala Val Asn Thr Glu Gly Val 
705                 710                 715                 720 


Tyr Ser Glu Pro Arg Pro Ile Gly Thr Arg Tyr Leu Thr Arg Asn Leu 
                725                 730                 735     


<210> 12
<211> 46
<212> PRT
<213> Adeno-associated virus

<400> 12
Tyr Leu Gly Pro Gly Asn Gly Leu Asp Lys Gly Glu Pro Val Asn Ala 
1               5                   10                  15      


Ala Asp Ala Ala Ala Leu Glu His Asp Lys Ala Tyr Asp Gln Gln Leu 
            20                  25                  30          


Lys Ala Gly Asp Asn Pro Tyr Leu Lys Tyr Asn His Ala Asp 
        35                  40                  45      


<210> 13
<211> 183
<212> DNA
<213> Adeno-associated virus

<400> 13
aagagccaga ctcctcctcg ggcattggca agacaggcca gcagcccgct aaaaagagac       60

tcaattttgg tcagactggc gactcagagt cagtccccga cccacaacct ctcggagaac      120

ctccagcaac ccccgctgct gtgggaccta ctacaatggc ttcaggcggt ggcgcaccaa      180

tgg                                                                    183


<210> 14
<211> 183
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polynucleotide"

<400> 14
aagagccaga ctcctccgcg ggtattggca aatcgggtgc acagcccgct aaaaagagac       60

tcaatttcgg tcagactggc gacacagagt cagtcccaga ccctcaacca atcggagaac      120

ctcccgcagc cccctcaggt gtgggatctc ttacaatggc ttcaggcggt ggcgcaccaa      180

tgg                                                                    183


<210> 15
<211> 5
<212> PRT
<213> Adeno-associated virus

<400> 15
Glu Pro Pro Ala Thr 
1               5   


<210> 16
<211> 52
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"


<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Lys"

<220>
<221> VARIANT
<222> (44)..(44)
<223> /replace="Ala" or "Gly"

<220>
<221> VARIANT
<222> (47)..(47)
<223> /replace="Ala" or "Pro"

<220>
<221> SITE
<222> (1)..(52)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 16
Asp Ser Ser Ser Gly Ile Gly Lys Ser Gly Gln Gln Pro Ala Arg Lys 
1               5                   10                  15      


Arg Leu Asn Phe Gly Gln Thr Gly Asp Ser Glu Ser Val Pro Asp Pro 
            20                  25                  30          


Gln Pro Leu Gly Glu Pro Pro Ala Ala Pro Ser Ser Val Gly Ser Asn 
        35                  40                  45              


Thr Met Ala Ser 
    50          


<210> 17
<211> 52
<212> PRT
<213> Adeno-associated virus

<400> 17
Asp Ser Ser Ser Gly Val Gly Lys Ser Gly Lys Gln Pro Ala Arg Lys 
1               5                   10                  15      


Arg Leu Asn Phe Gly Gln Thr Gly Asp Ser Glu Ser Val Pro Asp Pro 
            20                  25                  30          


Gln Pro Leu Gly Glu Pro Pro Ala Ala Pro Thr Ser Leu Gly Ser Asn 
        35                  40                  45              


Thr Met Ala Ser 
    50          


<210> 18
<211> 44
<212> PRT
<213> Adeno-associated virus

<400> 18
Lys Lys Ala Arg Thr Glu Glu Asp Ser Lys Pro Ser Thr Ser Ser Asp 
1               5                   10                  15      


Ala Glu Ala Gly Pro Ser Gly Ser Gln Gln Leu Gln Ile Pro Ala Gln 
            20                  25                  30          


Pro Ala Ser Ser Leu Gly Ala Asp Thr Met Ser Ala 
        35                  40                  


<210> 19
<211> 52
<212> PRT
<213> Adeno-associated virus

<400> 19
Asp Ser Ser Ser Gly Ile Gly Lys Thr Gly Gln Gln Pro Ala Lys Lys 
1               5                   10                  15      


Arg Leu Asn Phe Gly Gln Thr Gly Asp Ser Glu Ser Val Pro Asp Pro 
            20                  25                  30          


Gln Pro Leu Gly Glu Pro Pro Ala Thr Pro Ala Ala Val Gly Pro Thr 
        35                  40                  45              


Thr Met Ala Ser 
    50          


<210> 20
<211> 52
<212> PRT
<213> Adeno-associated virus

<400> 20
Asp Ser Ser Thr Gly Ile Gly Lys Lys Gly Gln Gln Pro Ala Arg Lys 
1               5                   10                  15      


Arg Leu Asn Phe Gly Gln Thr Gly Asp Ser Glu Ser Val Pro Asp Pro 
            20                  25                  30          


Gln Pro Leu Gly Glu Pro Pro Ala Ala Pro Ser Gly Val Gly Pro Asn 
        35                  40                  45              


Thr Met Ala Ala 
    50          


<210> 21
<211> 52
<212> PRT
<213> Adeno-associated virus

<400> 21
Asp Ser Ser Ala Gly Ile Gly Lys Ser Gly Ala Gln Pro Ala Lys Lys 
1               5                   10                  15      


Arg Leu Asn Phe Gly Gln Thr Gly Asp Thr Glu Ser Val Pro Asp Pro 
            20                  25                  30          


Gln Pro Ile Gly Glu Pro Pro Ala Ala Pro Ser Gly Val Gly Ser Leu 
        35                  40                  45              


Thr Met Ala Ser 
    50          


<210> 22
<211> 51
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"


<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Arg"

<220>
<221> SITE
<222> (1)..(51)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 22
Asp Ser Ser Ser Gly Ile Gly Lys Lys Gly Gln Gln Pro Ala Lys Lys 
1               5                   10                  15      


Arg Leu Asn Phe Gly Gln Thr Gly Asp Ser Glu Ser Val Pro Asp Pro 
            20                  25                  30          


Gln Pro Leu Gly Glu Pro Pro Ala Ala Pro Ser Gly Val Gly Ser Asn 
        35                  40                  45              


Thr Met Ala 
    50      


<210> 23
<211> 51
<212> PRT
<213> Adeno-associated virus

<400> 23
Asp Ser Ser Ser Gly Ile Gly Lys Thr Gly Gln Gln Pro Ala Lys Lys 
1               5                   10                  15      


Arg Leu Asn Phe Gly Gln Thr Gly Asp Ser Glu Ser Val Pro Asp Pro 
            20                  25                  30          


Gln Pro Leu Gly Glu Pro Pro Ala Thr Pro Ala Ala Val Gly Pro Thr 
        35                  40                  45              


Thr Met Ala 
    50      


<210> 24
<211> 51
<212> PRT
<213> Adeno-associated virus

<400> 24
Asp Ser Ser Ser Gly Thr Gly Lys Ala Gly Gln Gln Pro Ala Arg Lys 
1               5                   10                  15      


Arg Leu Asn Phe Gly Gln Thr Gly Asp Ala Asp Ser Val Pro Asp Pro 
            20                  25                  30          


Gln Pro Leu Gly Gln Pro Pro Ala Ala Pro Ser Gly Leu Gly Thr Asn 
        35                  40                  45              


Thr Met Ala 
    50      


<210> 25
<211> 51
<212> PRT
<213> Adeno-associated virus

<400> 25
Asp Ser Ser Ser Gly Val Gly Lys Ser Gly Lys Gln Pro Ala Arg Lys 
1               5                   10                  15      


Arg Leu Asn Phe Gly Gln Thr Gly Asp Ser Glu Ser Val Pro Asp Pro 
            20                  25                  30          


Gln Pro Leu Gly Glu Pro Pro Ala Ala Pro Thr Ser Leu Gly Ser Asn 
        35                  40                  45              


Thr Met Ala 
    50      


<210> 26
<211> 46
<212> PRT
<213> Adeno-associated virus

<400> 26
Asp Ser Ser Thr Gly Ile Gly Lys Lys Gly Lys Gln Pro Ala Lys Lys 
1               5                   10                  15      


Lys Leu Val Phe Glu Asp Glu Thr Gly Ala Gly Asp Gly Pro Pro Glu 
            20                  25                  30          


Gly Ser Thr Ser Gly Ala Met Ser Asp Asp Ser Glu Met Arg 
        35                  40                  45      


<210> 27
<211> 51
<212> PRT
<213> Adeno-associated virus

<400> 27
Asp Ser Ser Thr Gly Ile Gly Lys Lys Gly Gln Gln Pro Ala Arg Lys 
1               5                   10                  15      


Arg Leu Asn Phe Gly Gln Thr Gly Asp Ser Glu Ser Val Pro Asp Pro 
            20                  25                  30          


Gln Pro Leu Gly Glu Pro Pro Ala Ala Pro Ser Ser Val Gly Ser Gly 
        35                  40                  45              


Thr Val Ala 
    50      


<210> 28
<211> 51
<212> PRT
<213> Adeno-associated virus

<400> 28
Asp Ser Ser Thr Gly Ile Gly Lys Lys Gly Gln Gln Pro Ala Arg Lys 
1               5                   10                  15      


Arg Leu Asn Phe Gly Gln Thr Gly Asp Ser Glu Ser Val Pro Asp Pro 
            20                  25                  30          


Gln Pro Leu Gly Glu Pro Pro Ala Ala Pro Ser Gly Val Gly Pro Asn 
        35                  40                  45              


Thr Met Ala 
    50      


<210> 29
<211> 51
<212> PRT
<213> Adeno-associated virus

<400> 29
Asp Ser Ser Ala Gly Ile Gly Lys Ser Gly Ala Gln Pro Ala Lys Lys 
1               5                   10                  15      


Arg Leu Asn Phe Gly Gln Thr Gly Asp Thr Glu Ser Val Pro Asp Pro 
            20                  25                  30          


Gln Pro Ile Gly Glu Pro Pro Ala Ala Pro Ser Gly Val Gly Ser Leu 
        35                  40                  45              


Thr Met Ala 
    50      


<210> 30
<211> 51
<212> PRT
<213> Adeno-associated virus

<400> 30
Asp Ser Ser Thr Gly Ile Gly Lys Lys Gly Gln Gln Pro Ala Lys Lys 
1               5                   10                  15      


Arg Leu Asn Phe Gly Gln Thr Gly Glu Ser Glu Ser Val Pro Asp Pro 
            20                  25                  30          


Gln Pro Ile Gly Glu Pro Pro Ala Gly Pro Ser Gly Leu Gly Ser Gly 
        35                  40                  45              


Thr Met Ala 
    50      


<210> 31
<211> 46
<212> PRT
<213> Adeno-associated virus

<400> 31
Asp Ser Ser Ser Gly Ile Gly Lys Lys Gly Lys Gln Pro Ala Arg Lys 
1               5                   10                  15      


Arg Leu Asn Phe Glu Glu Asp Thr Gly Ala Gly Asp Gly Pro Pro Glu 
            20                  25                  30          


Gly Ser Asp Thr Ser Ala Met Ser Ser Asp Ile Glu Met Arg 
        35                  40                  45      


<210> 32
<211> 57
<212> PRT
<213> Adeno-associated virus

<400> 32
Pro Gln Glu Pro Asp Ser Ser Ser Gly Ile Gly Lys Thr Gly Gln Gln 
1               5                   10                  15      


Pro Ala Lys Lys Arg Leu Asn Phe Gly Gln Thr Gly Asp Ser Glu Ser 
            20                  25                  30          


Val Pro Asp Pro Gln Pro Leu Gly Glu Pro Pro Ala Thr Pro Ala Ala 
        35                  40                  45              


Val Gly Pro Thr Thr Met Ala Ser Gly 
    50                  55          


<210> 33
<211> 57
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 33
Pro Gln Glu Pro Asp Ser Ser Ala Gly Ile Gly Lys Ser Gly Ala Gln 
1               5                   10                  15      


Pro Ala Lys Lys Arg Leu Asn Phe Gly Gln Thr Gly Asp Thr Glu Ser 
            20                  25                  30          


Val Pro Asp Pro Gln Pro Ile Gly Glu Pro Pro Ala Ala Pro Ser Gly 
        35                  40                  45              


Val Gly Ser Leu Thr Met Ala Ser Gly 
    50                  55          


<210> 34
<211> 57
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 34
Pro Gln Glu Pro Asp Ser Ser Ser Gly Ile Gly Lys Thr Gly Gln Gln 
1               5                   10                  15      


Pro Ala Lys Lys Arg Leu Asn Phe Gly Gln Thr Gly Asp Thr Glu Ser 
            20                  25                  30          


Val Pro Asp Pro Gln Pro Ile Gly Glu Pro Pro Ala Ala Pro Ser Gly 
        35                  40                  45              


Val Gly Ser Leu Thr Met Ala Ser Gly 
    50                  55          


<210> 35
<211> 57
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 35
Pro Gln Glu Pro Asp Ser Ser Ser Gly Ile Gly Lys Thr Gly Gln Gln 
1               5                   10                  15      


Pro Ala Lys Lys Arg Leu Asn Phe Gly Gln Thr Gly Asp Thr Glu Ser 
            20                  25                  30          


Val Pro Asp Pro Gln Pro Ile Gly Glu Pro Pro Ala Ala Pro Ser Gly 
        35                  40                  45              


Val Gly Pro Thr Thr Met Ala Ser Gly 
    50                  55          


<210> 36
<211> 57
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 36
Pro Gln Glu Pro Asp Ser Ser Ser Gly Ile Gly Lys Thr Gly Gln Gln 
1               5                   10                  15      


Pro Ala Lys Lys Arg Leu Asn Phe Gly Gln Thr Gly Asp Ser Glu Ser 
            20                  25                  30          


Val Pro Asp Pro Gln Pro Leu Gly Glu Pro Pro Ala Ala Pro Ser Gly 
        35                  40                  45              


Val Gly Ser Leu Thr Met Ala Ser Gly 
    50                  55          


<210> 37
<211> 57
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 37
Pro Gln Glu Pro Asp Ser Ser Ala Gly Ile Gly Lys Ser Gly Ala Gln 
1               5                   10                  15      


Pro Ala Lys Lys Arg Leu Asn Phe Gly Gln Thr Gly Asp Ser Glu Ser 
            20                  25                  30          


Val Pro Asp Pro Gln Pro Leu Gly Glu Pro Pro Ala Thr Pro Ala Ala 
        35                  40                  45              


Val Gly Pro Thr Thr Met Ala Ser Gly 
    50                  55          


<210> 38
<211> 150
<212> DNA
<213> Adeno-associated virus

<400> 38
gccagcagcc cgctaaaaag agactcaatt ttggtcagac tggcgactca gagtcagtcc       60

ccgacccaca acctctcgga gaacctccag caacccccgc tgctgtggga cctactacaa      120

tggcttcagg cggtggcgca ccaatggcag                                       150


<210> 39
<211> 49
<212> PRT
<213> Adeno-associated virus


<220>
<221> VARIANT
<222> (14)..(14)
<223> /replace="Met"

<220>
<221> SITE
<222> (1)..(49)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 39
Gly Gln Gln Pro Ala Lys Lys Arg Leu Asn Phe Gly Gln Leu Ala Thr 
1               5                   10                  15      


Gln Ser Gln Ser Pro Thr His Asn Leu Ser Glu Asn Leu Gln Gln Pro 
            20                  25                  30          


Pro Leu Leu Trp Asp Leu Leu Gln Trp Leu Gly Gly Gly Ala Pro Met 
        35                  40                  45              


Ala 
    


<210> 40
<211> 150
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polynucleotide"

<400> 40
gtgcacagcc cgctaaaaag agactcaatt tcggtcagac tggcgacaca gagtcagtcc       60

cagaccctca accaatcgga gaacctcccg cagccccctc aggtgtggga tctcttacaa      120

tggcttcagg cggtggcgca ccaatggcag                                       150


<210> 41
<211> 49
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"


<220>
<221> VARIANT
<222> (14)..(14)
<223> /replace="Met"

<220>
<221> SITE
<222> (1)..(49)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 41
Gly Ala Gln Pro Ala Lys Lys Arg Leu Asn Phe Gly Gln Leu Ala Thr 
1               5                   10                  15      


Gln Ser Gln Ser Gln Thr Leu Asn Gln Ser Glu Asn Leu Pro Gln Pro 
            20                  25                  30          


Pro Gln Val Trp Asp Leu Leu Gln Trp Leu Gly Gly Gly Ala Pro Met 
        35                  40                  45              


Ala 
    


<210> 42
<211> 150
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polynucleotide"

<400> 42
gccagcagcc cgctaaaaag agactcaatt ttggtcagac tggcgacaca gagtcagtcc       60

ccgacccaca acctatcgga gaacctccag cagccccctc aggtgtggga tctcttacaa      120

tggcttcagg cggtggcgca ccaatggcag                                       150


<210> 43
<211> 49
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"


<220>
<221> VARIANT
<222> (14)..(14)
<223> /replace="Met"

<220>
<221> SITE
<222> (1)..(49)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 43
Gly Gln Gln Pro Ala Lys Lys Arg Leu Asn Phe Gly Gln Leu Ala Thr 
1               5                   10                  15      


Gln Ser Gln Ser Pro Thr His Asn Leu Ser Glu Asn Leu Gln Gln Pro 
            20                  25                  30          


Pro Gln Val Trp Asp Leu Leu Gln Trp Leu Gly Gly Gly Ala Pro Met 
        35                  40                  45              


Ala 
    


<210> 44
<211> 150
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polynucleotide"

<400> 44
gccagcagcc cgctaaaaag agactcaatt ttggtcagac tggcgacaca gagtcagtcc       60

ccgacccaca acctatcgga gaacctccag cagccccctc aggtgtggga cctactacaa      120

tggcttcagg cggtggcgca ccaatggcag                                       150


<210> 45
<211> 150
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polynucleotide"

<400> 45
gccagcagcc cgctaaaaag agactcaatt ttggtcagac tggcgactca gagtcagtcc       60

ccgacccaca acctctcgga gaacctccag cagccccctc aggtgtggga tctcttacaa      120

tggcttcagg cggtggcgca ccaatggcag                                       150


<210> 46
<211> 150
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polynucleotide"

<400> 46
gcgcgcagcc cgctaaaaag agactcaatt ttggtcagac tggcgactca gagtcagtcc       60

ccgacccaca acctctcgga gaacctccag caacccccgc tgctgtggga cctactacaa      120

tggcttcagg cggtggcgca ccaatggcag                                       150


<210> 47
<211> 49
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"


<220>
<221> VARIANT
<222> (14)..(14)
<223> /replace="Met"

<220>
<221> SITE
<222> (1)..(49)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 47
Gly Ala Gln Pro Ala Lys Lys Arg Leu Asn Phe Gly Gln Leu Ala Thr 
1               5                   10                  15      


Gln Ser Gln Ser Pro Thr His Asn Leu Ser Glu Asn Leu Gln Gln Pro 
            20                  25                  30          


Pro Leu Leu Trp Asp Leu Leu Gln Trp Leu Gly Gly Gly Ala Pro Met 
        35                  40                  45              


Ala 
    


<210> 48
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 48
Met Ala Thr Gln Ser Gln Ser Pro Thr Leu Asn Leu Ser Glu Asn Leu 
1               5                   10                  15      


Gln Gln Pro Pro Leu Val Trp Asp Leu Leu Gln Trp Leu Gln 
            20                  25                  30  


<210> 49
<211> 30
<212> PRT
<213> Adeno-associated virus

<400> 49
Met Ala Thr Gln Ser Gln Ser Pro Ile His Asn Leu Ser Glu Asn Leu 
1               5                   10                  15      


Gln Gln Pro Pro Leu Leu Trp Asp Leu Leu Gln Trp Leu Gln 
            20                  25                  30  


<210> 50
<211> 30
<212> PRT
<213> Adeno-associated virus

<400> 50
Met Glu Thr Gln Thr Gln Tyr Leu Thr Pro Ser Leu Ser Asp Ser His 
1               5                   10                  15      


Gln Gln Pro Pro Leu Val Trp Glu Leu Ile Arg Trp Leu Gln 
            20                  25                  30  


<210> 51
<211> 30
<212> PRT
<213> Adeno-associated virus

<400> 51
Met Ala Thr Gln Ser Gln Ser Gln Thr Leu Asn Leu Ser Glu Asn His 
1               5                   10                  15      


Gln Gln Pro Pro Gln Val Trp Asp Leu Ile Gln Trp Leu Gln 
            20                  25                  30  


<210> 52
<211> 24
<212> PRT
<213> Adeno-associated virus

<400> 52
Met Glu Gln Ala Thr Asp Pro Leu Arg Asp Gln Leu Pro Glu Pro Cys 
1               5                   10                  15      


Leu Met Thr Val Arg Cys Val Gln 
            20                  


<210> 53
<211> 30
<212> PRT
<213> Adeno-associated virus

<400> 53
Met Ala Thr Gln Ser Gln Ser Pro Thr Leu Asn Leu Ser Glu Asn Leu 
1               5                   10                  15      


Gln Gln Arg Pro Leu Val Trp Asp Leu Val Gln Trp Leu Gln 
            20                  25                  30  


<210> 54
<211> 30
<212> PRT
<213> Adeno-associated virus

<400> 54
Met Ala Thr Gln Ser Gln Phe Gln Thr Leu Asn Leu Ser Glu Asn Leu 
1               5                   10                  15      


Gln Gln Arg Pro Leu Val Trp Asp Leu Ile Gln Trp Leu Gln 
            20                  25                  30  


<210> 55
<211> 30
<212> PRT
<213> Adeno-associated virus

<400> 55
Met Ala Ser Gln Ser Gln Ser Pro Thr Leu Asn Gln Ser Glu Asn His 
1               5                   10                  15      


Gln Gln Ala Pro Leu Val Trp Asp Leu Val Gln Trp Leu Gln 
            20                  25                  30  


<210> 56
<211> 24
<212> PRT
<213> Adeno-associated virus

<400> 56
Met Glu Pro Glu Thr Asp Pro Leu Lys Asp Gln Ile Pro Ala Pro Cys 
1               5                   10                  15      


Leu Gln Thr Leu Lys Cys Val Gln 
            20                  


